Computer-aided detection (CAD) firm VuCOMP has received U.S. Food and Drug Administration (FDA) approval for mammography version 3.1 of its M-Vu CAD software.
The company said it's also releasing an update to its CAD station that adds the ability to process additional standard screening views. The two updates bring faster processing time, enhanced workflow, and improved parallel architecture, according to VuCOMP.